pathogenesis are not fully understood and might be elucidated by identifying novel disease-related molec-ular markers, including autoantigens. METHODS: We used 2 proteomic methods to analyze plasma samples from 20 psoriasis patients and 20 matched healthy donors. The first method focused on evaluating changes in glycoprotein concentrations and the plasma proteome, and the second method assessed endogenous proteolytic activity by analyzing the low molecular weight component of plasma. RESULTS: The integrated proteomic and peptidomic analysis identified a number of proteins and their frag-ments present at different concentrations in the plasma of psoriasis patients and healthy donors. We used ELISA to independently verify the changes in the c...
Biological therapies, which include antitumour necrosis factor-α and T-cell inhibitors, are potentia...
Psoriasis is a chronic inflammatory skin disease induced by multifactorial causes and is characteriz...
Differentially expressed proteins previously identified by Ryu et al. [20]. Ryu et al. identified 36...
pathogenesis are not fully understood and might be elucidated by identifying novel disease-related m...
Psoriasis has been thought to be driven primarily by innate and adaptive immune systems that can be ...
There is a high prevalence of undiagnosed PsA in psoriasis patients; therefore identifying soluble b...
Abstract Background Psoriatic arthritis (PsA) is a di...
Psoriatic arthritis (PsA) is an inflammatory arthritis which develops in up to one-third of patients...
Abstract Background Biomarkers for distinguishing psoriatic arthritis (PsA) from psoriasis without a...
Psoriasis is a chronic, immune-mediated inflammatory skin disease with severe consequences for the w...
BACKGROUND Biomarkers for distinguishing psoriatic arthritis (PsA) from psoriasis without arthrit...
Psoriasis is a disease with considerable heterogeneity in clinical presentation. This is the first s...
To better understand the pathomechanism of psoriasis, a comparative proteomic analysis was performed...
Background : Psoriasis is a common, chronic, recurrent, inflammatory disease of the skin characteriz...
Abstract Background Synovial fluid (SF) is a dynamic ...
Biological therapies, which include antitumour necrosis factor-α and T-cell inhibitors, are potentia...
Psoriasis is a chronic inflammatory skin disease induced by multifactorial causes and is characteriz...
Differentially expressed proteins previously identified by Ryu et al. [20]. Ryu et al. identified 36...
pathogenesis are not fully understood and might be elucidated by identifying novel disease-related m...
Psoriasis has been thought to be driven primarily by innate and adaptive immune systems that can be ...
There is a high prevalence of undiagnosed PsA in psoriasis patients; therefore identifying soluble b...
Abstract Background Psoriatic arthritis (PsA) is a di...
Psoriatic arthritis (PsA) is an inflammatory arthritis which develops in up to one-third of patients...
Abstract Background Biomarkers for distinguishing psoriatic arthritis (PsA) from psoriasis without a...
Psoriasis is a chronic, immune-mediated inflammatory skin disease with severe consequences for the w...
BACKGROUND Biomarkers for distinguishing psoriatic arthritis (PsA) from psoriasis without arthrit...
Psoriasis is a disease with considerable heterogeneity in clinical presentation. This is the first s...
To better understand the pathomechanism of psoriasis, a comparative proteomic analysis was performed...
Background : Psoriasis is a common, chronic, recurrent, inflammatory disease of the skin characteriz...
Abstract Background Synovial fluid (SF) is a dynamic ...
Biological therapies, which include antitumour necrosis factor-α and T-cell inhibitors, are potentia...
Psoriasis is a chronic inflammatory skin disease induced by multifactorial causes and is characteriz...
Differentially expressed proteins previously identified by Ryu et al. [20]. Ryu et al. identified 36...